| Monte Carlo methods in Bayesian computation MH Chen, QM Shao, JG Ibrahim Springer Science & Business Media, 2012 | 1548 | 2012 |
| Monte Carlo estimation of Bayesian credible and HPD intervals MH Chen, QM Shao Journal of computational and Graphical Statistics 8 (1), 69-92, 1999 | 1409 | 1999 |
| Improving marginal likelihood estimation for Bayesian phylogenetic model selection W Xie, PO Lewis, Y Fan, L Kuo, MH Chen Systematic biology 60 (2), 150-160, 2011 | 1118 | 2011 |
| Marital status and survival in patients with cancer AA Aizer, MH Chen, EP McCarthy, ML Mendu, S Koo, TJ Wilhite, ... Journal of clinical oncology 31 (31), 3869-3876, 2013 | 1113 | 2013 |
| Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy AV D'Amico, MH Chen, KA Roehl, WJ Catalona New England Journal of Medicine 351 (2), 125-135, 2004 | 989 | 2004 |
| Power prior distributions for regression models JG Ibrahim, MH Chen Statistical Science, 46-60, 2000 | 939 | 2000 |
| Androgen suppression and radiation vs radiation alone for prostate cancer: a randomized trial AV D’Amico, MH Chen, AA Renshaw, M Loffredo, PW Kantoff Jama 299 (3), 289-295, 2008 | 904 | 2008 |
| A new Bayesian model for survival data with a surviving fraction MH Chen, JG Ibrahim, D Sinha Journal of the American Statistical Association 94 (447), 909-919, 1999 | 638 | 1999 |
| Missing-data methods for generalized linear models: A comparative review JG Ibrahim, MH Chen, SR Lipsitz, AH Herring Journal of the American Statistical Association 100 (469), 332-346, 2005 | 613 | 2005 |
| Androgen deprivation therapy for localized prostate cancer and the risk of cardiovascular mortality HK Tsai, AV D’Amico, N Sadetsky, MH Chen, PR Carroll Journal of the National Cancer Institute 99 (20), 1516-1524, 2007 | 602 | 2007 |
| Cancer-specific mortality after surgery or radiation for patients with clinically localized prostate cancer managed during the prostate-specific antigen era AV D’Amico, J Moul, PR Carroll, L Sun, D Lubeck, MH Chen Journal of clinical oncology 21 (11), 2163-2172, 2003 | 598 | 2003 |
| Surrogate end point for prostate cancer–specific mortality after radical prostatectomy or radiation therapy AV D’Amico, JW Moul, PR Carroll, L Sun, D Lubeck, MH Chen Journal of the National Cancer Institute 95 (18), 1376-1383, 2003 | 594 | 2003 |
| Influence of androgen suppression therapy for prostate cancer on the frequency and timing of fatal myocardial infarctions AV D'Amico, JW Denham, J Crook, MH Chen, SZ Goldhaber, DS Lamb, ... Journal of Clinical Oncology 25 (17), 2420-2425, 2007 | 587 | 2007 |
| Pretreatment nomogram for prostate-specific antigen recurrence after radical prostatectomy or external-beam radiation therapy for clinically localized prostate cancer AV D'Amico, R Whittington, SB Malkowicz, J Fondurulia, MH Chen, ... Journal of Clinical Oncology 17 (1), 168-168, 1999 | 496 | 1999 |
| Biochemical outcome after radical prostatectomy or external beam radiation therapy for patients with clinically localized prostate carcinoma in the prostate specific antigen era AV D'Amico, R Whittington, SB Malkowicz, K Cote, M Loffredo, D Schultz, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2002 | 472 | 2002 |
| Pretreatment PSA velocity and risk of death from prostate cancer following external beam radiation therapy AV D’Amico, AA Renshaw, B Sussman, MH Chen Jama 294 (4), 440-447, 2005 | 398 | 2005 |
| Missing covariates in generalized linear models when the missing data mechanism is non‐ignorable JG Ibrahim, SR Lipsitz, MH Chen Journal of the Royal Statistical Society: Series B (Statistical Methodology …, 1999 | 367 | 1999 |
| Hormonal therapy use for prostate cancer and mortality in men with coronary artery disease–induced congestive heart failure or myocardial infarction A Nanda, MH Chen, MH Braccioforte, BJ Moran, AV D’Amico Jama 302 (8), 866-873, 2009 | 335 | 2009 |
| The power prior: theory and applications JG Ibrahim, MH Chen, Y Gwon, F Chen Statistics in medicine 34 (28), 3724-3749, 2015 | 333 | 2015 |
| Clinical utility of the percentage of positive prostate biopsies in defining biochemical outcome after radical prostatectomy for patients with clinically localized prostate cancer AV D’Amico, R Whittington, SB Malkowicz, D Schultz, J Fondurulia, ... Journal of clinical oncology 18 (6), 1164-1172, 2000 | 329 | 2000 |
Joseph G. IbrahimUNCVerified email at bios.unc.edu
